FindMyKOL
Clinical trialNCT02407496CompletedObservational

Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)

NCT02407496 is an observational study sponsored by Think Now Incorporated. As of 21 Nov 2026, it is completed. It studies Attention Deficit Hyperactivity Disorder (ADHD). The registry lists an enrollment of 80 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2014 and a primary completion date of 31 Jul 2015.

SponsorThink Now IncorporatedEnrollment80Attention Deficit Hyperactivity Disorder (ADHD)
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02407496
FieldValue
Registry IDNCT02407496
StatusCompleted
Study typeObservational study
Lead sponsorThink Now Incorporated
Enrollment80
Registered sites1
Countries1
ConditionsAttention Deficit Hyperactivity Disorder (ADHD)
Start30 Jun 2014
Primary completion31 Jul 2015
Study completion30 Sept 2015
Last update posted10 Dec 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is develop a new assessment tool for Attention Deficit-Hyperactivity Disorder (ADHD) and to then test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Ucla Semel Institute

    Los Angeles

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02407496

Each answer restates registry values shown on this page.

What is NCT02407496?

NCT02407496 is an observational study sponsored by Think Now Incorporated. It studies Attention Deficit Hyperactivity Disorder (ADHD).

Who leads NCT02407496?

The registry names Gregory V Simpson, Ph.D. (principal investigator, Think Now, Inc.) and Mark S Cohen, Ph.D. (study director, University of California, Los Angeles) as overall officials.

Where does NCT02407496 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02407496 end?

The registry lists a primary completion date of 31 Jul 2015 and a study completion date of 30 Sept 2015. The sponsor last updated the record on 10 Dec 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.